EXPANSION THERAPEUTICS

expansion-therapeutics-logo

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases.

#SimilarOrganizations #People #Financial #Event #Website #More

EXPANSION THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2016-01-01

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.expansionrx.com

Total Employee:
11+

Status:
Active

Contact:
(858) 764-4290

Email Addresses:
[email protected]

Total Funding:
135.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Microsoft Exchange Online Office 365 Mail GoDaddy DNS


Similar Organizations

acrivon-therapeutics-logo

Acrivon Therapeutics

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

egle-therapeutics-logo

Egle Therapeutics

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

lycia-therapeutics-logo

Lycia Therapeutics

Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.

qed-therapeutics-logo

QED Therapeutics

QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.

ribon-therapeutics-logo

Ribon Therapeutics

Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.

semma-therapeutics-logo

Semma Therapeutics

Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.

siolta-therapeutics-logo

Siolta Therapeutics

Siolta Therapeutics is a biotech company focused on developing therapeutic microbial consortia to prevent and treat inflammatory diseases.

tensixteen-bio-logo

TenSixteen Bio

TenSixteen Bio is a biotechnology company focused on developing novel therapeutics for a variety of diseases.

vigil-neuroscience-logo

Vigil Neuroscience

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.


Current Advisors List

beth-seidenberg_image

Beth Seidenberg Board Member @ Expansion Therapeutics
Board_member

campbell-murray_image

Campbell Murray Board Member @ Expansion Therapeutics
Board_member

yujiro-s-hata_image

Yujiro S. Hata Board of Directors @ Expansion Therapeutics
Board_member
2017-03-01

matthew-d-disney_image

Matthew D. Disney Board Member @ Expansion Therapeutics
Board_member

kevin-forrest_image

Kevin Forrest Board Member @ Expansion Therapeutics
Board_member

eric-wang_image

Eric Wang Scientific Advisor @ Expansion Therapeutics
Advisor

jason-p-hafler_image

Jason P. Hafler Board Member @ Expansion Therapeutics
Board_member

scott-m-rocklage_image

Scott M. Rocklage Chairman @ Expansion Therapeutics
Board_member

Current Employees Featured

matthew-d-disney_image

Matthew D. Disney
Matthew D. Disney Scientific Founder @ Expansion Therapeutics
Scientific Founder

brian-daniels_image

Brian Daniels
Brian Daniels CMO @ Expansion Therapeutics
CMO

sudhir-rao_image

Sudhir Rao
Sudhir Rao SVP of Business Development @ Expansion Therapeutics
SVP of Business Development
2022-01-01

renato-skerlj_image

Renato Skerlj
Renato Skerlj Chief Executive Officer @ Expansion Therapeutics
Chief Executive Officer
2020-10-01

valerie-cullen_image

Valerie Cullen
Valerie Cullen Senior Vice President, Research @ Expansion Therapeutics
Senior Vice President, Research
2021-05-01

jason-ruth_image

Jason Ruth
Jason Ruth Principal @ Expansion Therapeutics
Principal
2020-01-01

Founder


kevin-forrest_image

Kevin Forrest

matthew-d-disney_image

Matthew D. Disney

Investors List

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series B - Expansion Therapeutics

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series B - Expansion Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series B - Expansion Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Expansion Therapeutics

kleiner-perkins-caufield-byers_image

Kleiner Perkins

Kleiner Perkins investment in Series B - Expansion Therapeutics

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Expansion Therapeutics

westlake-village-biopartners_image

Westlake Village BioPartners

Westlake Village BioPartners investment in Series B - Expansion Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Expansion Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Expansion Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series A - Expansion Therapeutics

Official Site Inspections

http://www.expansionrx.com Semrush global rank: 4.98 M Semrush visits lastest month: 1.69 K

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "Expansion Therapeutics"

LeadershipTeam - Expansionrx

We believe that the development of small molecule drugs that modulate RNA will dramatically change patient outcomes for diseases where treatment options for patients ...See details»

Expansion Therapeutics - Crunchbase Company Profile โ€ฆ

Jan 4, 2018 Organization. Expansion Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Expansion Therapeutics is a biotechnology company focusing on โ€ฆSee details»

Expansion Therapeutics - LinkedIn

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual ...See details»

Expansion Therapeutics Announces Key Additions and โ€ฆ

Mar 2, 2023 Kenneth S. Kosik, M.D. โ€“ Dr. Kosik is the Harriman Professor of Neuroscience Research and Co-Director of the Neuroscience Research Institute at the University of California, Santa Barbara. Previously, he was full professor โ€ฆSee details»

Expansion Therapeutics Company Overview, Contact Details

Expansionrx hired Melissa A. Starovasnik as Scientific Advisory Board on Mar 2nd '23. Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral โ€ฆSee details»

Expansion Therapeutics - PitchBook

Information on valuation, funding, cap tables, investors, and executives for Expansion Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Working at Expansion Therapeutics - Zippia

Mar 14, 2024 www.expansionrx.com. Organization Type. Private. Social Media. Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of โ€ฆSee details»

Expansion Therapeutics Announces Key Additions and Updates to ...

Mar 2, 2023 Prior to that, as Vice President, Research Operations and Structural Biology, she coordinated all operational activities for the more than 1300-member Genentech research โ€ฆSee details»

Expansion Therapeutics Raises $80 Million Series B Financing to โ€ฆ

Sep 29, 2021 Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of severe RNA-mediated โ€ฆSee details»

Expansion Therapeutics Raises $55.3 Million in Series A Financing โ€ฆ

About Myotonic Dystrophy Type I Myotonic dystrophy type I (DM1) affects at least 1 in 8,000 people, or 40,000 individuals in the U.S. alone, and is the most frequent cause of adult onset โ€ฆSee details»

Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., โ€ฆ

Oct 26, 2022 Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today annoSee details»

Expansion Therapeutics Announces In-Licensing of Two New โ€ฆ

May 25, 2021 For more information, visit www.expansionrx.com. About the Rainwater Charitable Foundation The Rainwater Charitable Foundation (RCF) was created in the early 1990s by โ€ฆSee details»

Expansion Therapeutics Raises $80 Million Series B Financing to โ€ฆ

Sep 29, 2021 Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today announced the close โ€ฆSee details»

Expansion Therapeutics Announces Key Additions and Updates to ...

Mar 2, 2023 --World-renowned scientists and clinicians will guide Expansionโ€™s efforts to continue advancement of its small molecule RNA platform (SMIRNAโ„ข) BOSTON--(BUSINESS WIRE)- โ€ฆSee details»

PLATFORM - Expansionrx

We define druggable RNA structures by using knowledge of genetics and evolution We utilize proprietary tools and small molecule libraries, Chem-CLIP, NMR /docking /computational tools โ€ฆSee details»

Expansion Therapeutics Raises $80 Million Series B Financing to โ€ฆ

Sep 29, 2021 Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today annoSee details»

Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice ...

Jun 14, 2021 Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery. โ€œMark is a proven leader and drug hunter with more than 20 years of experience in the biotech industry and โ€ฆSee details»

INSIGHTS - Expansionrx

-- Recognized industry leader brings deep scientific and operational experience to Expansion board. Boston, January 19, 2022 -- Expansion...See details»

Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board โ€ฆ

Jan 19, 2022 Expansion Therapeutics, Inc., a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases, today annoSee details»

linkstock.net © 2022. All rights reserved